Evolus (NASDAQ:EOLS) Stock Rating Reaffirmed by Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a research report report published on Monday, Benzinga reports. Several other research analysts also recently weighed in on the company. HC Wainwright restated a buy rating and issued a $27.00 price target on shares of Evolus in a research note […]

Leave a Reply

Your email address will not be published.

Previous post Eli Lilly and Company (NYSE:LLY) Given Overweight Rating at Cantor Fitzgerald
Next post Needham & Company LLC Reiterates Buy Rating for PROS (NYSE:PRO)